Biogen Inc (NASDAQ:BIIB)

285.50
Delayed Data
As of Jan 17
 -0.64 / -0.22%
Today’s Change
215.78
Today|||52-Week Range
344.00
-3.78%
Year-to-Date
Why Biogen Stock Slumped Last Year
Jan 16 / MotleyFool.com - Paid Partner Content
Better Buy: Biogen vs. Gilead Sciences
Jan 11 / MotleyFool.com - Paid Partner Content
5 Reasons 2020 Will Be a Big Year for Ionis Pharmaceuticals
Jan 16 / MotleyFool.com - Paid Partner Content
Better Buy: AbbVie vs. Biogen
Jan 08 / MotleyFool.com - Paid Partner Content
New Research Shows Probiotics Can Help Prevent Parkinson's
Jan 14 / MotleyFool.com - Paid Partner Content
Better Buy: Gilead Sciences vs. Biogen
Jan 05 / MotleyFool.com - Paid Partner Content
Biogen Buys Azheimer's and Parkinson's Drug From Pfizer
Jan 13 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close286.14
Today’s open287.32
Day’s range284.90 - 288.00
Volume1,765,147
Average volume (3 months)2,034,657
Market cap$53.5B
Data as of 4:00pm ET, 01/17/2020

Growth & Valuation

Earnings growth (last year)+81.10%
Earnings growth (this year)+26.34%
Earnings growth (next 5 years)+5.99%
Revenue growth (last year)+9.67%
P/E ratio10.2
Price/Sales5.13
Price/Book4.34

Competitors

 Today’s
change
Today’s
% change
ILMNIllumina Inc-1.24-0.38%
GILDGilead Sciences-0.22-0.35%
BMRNBiomarin Pharmaceuti...-0.86-0.96%
EXASExact Sciences Corp-1.72-1.92%
Data as of 4:00pm ET, 01/17/2020

Financials

Next reporting dateJanuary 29, 2020
EPS forecast (this quarter)$7.92
Annual revenue (last year)$12.1B
Annual profit (last year)$4.4B
Net profit margin36.76%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts